Related Experiment Video
Updated: Jan 7, 2026

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions
Published on: August 26, 2021
Extracellular vesicles in viral disease management
Fatima Safeer1, Thokur Sreepathy Murali1
1Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Extracellular vesicles (EVs) show promise in diagnosing and treating viral diseases. These cell-derived vesicles can be engineered as alternatives to current antivirals, offering improved specificity and reduced toxicity for managing viral infections.
Area of Science:
- Biochemistry
- Cell Biology
- Virology
Background:
- Extracellular vesicles (EVs) are cell-released, lipid-bilayered bodies involved in intercellular communication.
- EVs share biological mechanisms with viruses, potentially aiding in viral dispersion and infection.
- EVs released by infected cells differ from those of healthy cells, offering diagnostic potential.
Purpose of the Study:
- To review studies on the diagnostic and therapeutic applications of EVs against viral diseases.
- To compare the benefits and limitations of EVs with existing antiviral treatments.
- To explore the potential of EVs in the medical sector for managing viral infections.
Main Methods:
- Review of existing literature on extracellular vesicles and viral diseases.
- Analysis of biomarker expression in EVs for diagnostic purposes.
- Evaluation of EVs' natural antiviral defense mechanisms and therapeutic potential.
Main Results:
- Elevated biomarker levels in EVs from infected cells are valuable for diagnostics.
- EVs possess inherent capabilities to combat viral infections, depending on their source.
- Exploiting EVs can lead to potent antiviral responses in hosts.
Conclusions:
- EVs can be developed as diagnostic tools for viral infections.
- EVs offer a natural defense against viruses that can be therapeutically harnessed.
- Overcoming challenges with EVs can lead to novel antiviral alternatives with better specificity and lower toxicity than current drugs.
More Related Videos
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Intralumenal Vesicles and Multivesicular Bodies
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Microorganisms in Medicine and Therapeutics
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...

